Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MSC-Exos in Peritoneal Dialysis-related Peritoneal Dysfunction
NCT07791667Phase 1Not yet recruiting
- Sponsor
- Southern Medical University Zhujiang Hospital
- Start
- Aug 2026
- Primary completion
- Jun 2027
01
Overview
Phase 1, open-label trial of mesenchymal stem cell exosomes (3 arms), sponsored by Southern Medical University Zhujiang Hospital. Primary endpoints: Incidence of Dose-Limiting Toxicities at 72 hours and Incidence of Serious Adverse Events at 4 weeks. Planned start Aug 2026; status: not yet recruiting.
02
Drugs
mesenchymal stem cell exosomes
Beyond the preview
Go deeper on NCT07791667.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07791667.